A Study to Assess the Drug Levels and Safety of BMS-986435 in Participants With Normal Hepatic Function and Participants With Different Degrees of Hepatic Impairment (clinicaltrials.gov) - Sep 21, 2026 - P1 | N=69 | Completed | Sponsor: Bristol-Myers Squibb | Recruiting ➔ Completed | N=24 ➔ 69
Enrollment change • Trial completion • Hepatology
|